Mateon Therapeutics Inc and Oncotelic Inc announced today that they have completed their previously announced merger The combined company has a focused pipeline of TGF RNA Therapeutics for late stage cancers including gliomas pancreatic cancer and melanoma
Salix Pharmaceuticals Salix one of the largest specialty pharmaceutical companies in the world committed to the prevention and treatment of gastrointestinal diseases and a wholly owned subsidiary of Bausch Health Companies Inc announced today that its affiliate has entered into an exclusive licensin...
ADC Therapeutics an oncology drug discovery and development company that specializes in the development of proprietary antibody drug conjugates ADCs and Adagene Inc an antibody engineering and discovery company today announced that they have entered into a discovery collaboration and license agreeme...
UroGen Pharma Ltd a clinicalstage biopharmaceutical company developing treatments to address unmet needs in the field of urooncology today announced that it has entered into an agreement with Janssen Research Development LLC Janssen to conduct an earlystage feasibility evaluation in a therapeutic a...
Eli Lilly and Company and Avidity Biosciences Inc today announced a global licensing and research collaboration focused on the discovery development and commercialization of potential new medicines in immunology and other select indications
Precigen Inc a whollyowned subsidiary of Intrexon Corporation and a clinical stage biopharmaceutical company specializing in the development of innovative gene and cellular therapies to improve the lives of patients today announced the official opening of its new manufacturing facility
Aurora Cannabis Inc announced today that the company has signed a binding share purchase agreement whereby Aurora has acquired all of the issued and outstanding common shares of privatelyheld Chemi Pharmaceutical Inc
The HNB Garhwal University A Central Universityhas got the First Indian Patent for years The research work Novel Synergistic Herbal Formulation of WithaniaSomnifera for Antihyperlipidemic and Antiobesity Activity was taken from MPharmacy student of the Department of Pharmaceutical Sciences of Garh...
La Jolla Pharmaceutical Company a leader in the discovery development and commercialization of innovative therapies intended to significantly improve outcomes in patients suffering from lifethreatening diseases today announced that the US Food and Drug Administration FDA has granted Breakthrough The...
Velabs Therapeutics specializing in the fast generation of functional therapeutic antibodies today announced that it has entered into an agreement with Chiome Bioscience Inc Tokyo to jointly discover modulatory and functional antibodies for one of Chiomes GPCR target genes
Maarefah management
TBA
The Conference Forum
Sheraton Imperial Hotel Raleigh
Maarefah management
Millennium Dubai Airport Hotel
CBI
TBD
Staff Engineer, Manufacturing Science and Technology, South East Asia
Karen Chan is a process engineer at Merck Pte Ltd Chan has six years of experience in the biopharmaceutical industry and two years of experience in research development She provides technical support in areas such as process development troubleshoot...Introduction The Human Immune deficiency Virus HIV infected brain cells through virus or HIV linked oncogenes The major complication of such infection leads to dementia peripheral neuropathies neurosyphilis meningitis etc The development of neuroAIDS still remains a topic of debate due to multifaceted symptom complicated pathology alon
Abstract Background Inflammatory breast cancer IBC is a rare aggressive form of breast cancer associated with HER amplification with high risk of metastasis and an estimated median survival of y We performed an openlabel singlearm phase II clinical trial ClinicalTrialsgov NCT to in
Abstract Background Slow and cumbersome laboratory diagnostics for Mycobacterium tuberculosis complex MTBC risk delayed treatment and poor patient outcomes Wholegenome sequencing WGS could potentially provide a rapid and comprehensive diagnostic solution In this prospective study we compare realtime
PhaseBio Pharmaceuticals is planning to announce PB a novel reversal agent for the Antiplatelet drug Ticagrelor PB is a novel recombinant human monoclonal antibody antigenbinding fragment or Fab fragment designed to reverse the Antiplatelet activity of ticagrelor in major bleeding and urgent surgery situations
Summary The target market for conducting global clinical trials has changed significantly moving beyond pharmaceutical early adopters to the mainstream marketplace This shift has placed a heightened focus on the language challenges and complexity of running a global clinical trial More and more companies are moving toward
In ethically promoting Pharma business field force are the resources who generate prescriptions for the products being promoted thus bring in revenue...
In the recent decades most of the pharmaceutical companies often look for extensions for their patented product to enhance the products life cycle by...
Visit the science and pharmacy colleges in the vicinity where the vacancies exist talk to the Placement Cell and then finalise a date which is conveni...
The key to successfully developing and shepherding a drug to the approval stage and beyond lies in careful planning right from the start of developmen...
Soft gels also known as soft capsules or soft caps are a highly popular pharmaceutical and nutraceutical dosage form with around units consumed every...
What are the major changes you see affecting todays pharmaceutical supply chain The primary change we see is that of market dynamics and rapid...
